Skip to main content

EPA Taps Cellumen for Second Phase of Toxcast Program

NEW YORK (GenomeWeb News) – Cellumen said today that it will provide analysis services for the second phase of the US Environmental Protection Agency's ToxCast program.

Cellumen said that the work with EPA "could generate" up to $5.5 million for the company, but did not disclose further financial details.

The company has been participating in the ToxCast program since 2007. In the first proof-of-concept phase, Cellumen generated hepatic toxicity data using its CellCiphr platform. Under the expanded agreement, the company will generate CellCiphr profiles for "thousands" of chemicals.

ToxCast is an EPA initiative that aims to reduce the time and costs associated with toxicity testing of chemicals.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.